Clinical laboratory
Healthcare issues related to clinical laboratories; FDA oversight of laboratory developed tests, including the discussion draft of the Verifying Accurate Leading-edge IVCT Development (VALID) Act; Medicare coverage and reimbursement levels for laboratory services and reforms to the Clinical Laboratory Fee Schedule including provisions contained in H.R. 3584, the Laboratory Access for Beneficiaries (LAB) Act ; federal policy relating to drug development; federal policy relating to anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Pub. L. 115-271 (18 U.S.C. 220); federal policy relating to subject matter eligibility for patents of laboratory tests.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
KELLEY DRYE & WARREN LLP
3050 K STREET, NW, SUITE 400, WASHINGTON, DC, 20007, US
DANA SCHNEEBERGER WOOD SCOTT MCGEE